Abbott Laboratories, Infectious Disease Research, Department 47N, Abbott Park, IL 60064, USA. richard.sciotti@pfizer.com
Abstract:
A novel series of antimicrobials of the oxazolidinone class is disclosed. These compounds are characterized relative to previously described analogues by a 'halostilbene-derived' pharmacophore and demonstrate enhanced antimicrobial activity against key Gram-positive pathogens when compared to Linezolid.